Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 37.28 is 177% above its 5-year average of 13.47, near the high end of its 5-year range (2.32–37.28).
As of the fiscal period ended Tuesday, June 30, 2026. 47.89% above its 12-month average of 25.21.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 37.28.
CURRENT RATIO
37.28
CURRENT RATIO AVG TTM
25.21
CURRENT RATIO AVG 3Y
16.79
CURRENT RATIO AVG 5Y
13.47
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+47.89%
CURRENT VS 3Y AVG
+122.11%
CURRENT VS 5Y AVG
+176.78%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+891.57%
vs the sector median at left
Trevi Therapeutics, Inc.
Market Cap
$1.87B
Current Ratio
37.28
TTM Avg
25.21
3Y Avg
16.79
5Y Avg
13.47
Market Cap
$1.89B
Current Ratio
10.22
TTM Avg
11.68
3Y Avg
12.23
5Y Avg
12.24
Market Cap
$1.84B
Current Ratio
21.18
TTM Avg
6.27
3Y Avg
4.65
5Y Avg
4.09
Market Cap
$1.83B
Current Ratio
4.42
TTM Avg
3.26
3Y Avg
3.65
5Y Avg
4.39
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Trevi Therapeutics, Inc. (TRVI) | $1.87B | 37.28 | 25.21 | 16.79 | 13.47 |
| Novavax, Inc. (NVAX)vs › | $1.86B | 2.33 | 1.55 | 1.13 | 1.26 |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 9.69 | 5.24 | 4.11 | 4.46 |
| Zymeworks Inc. (ZYME)vs › | $1.89B | 6.32 | 4.46 | 5.51 | 5.22 |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.89B | 10.22 | 11.68 | 12.23 | 12.24 |
| Immunome, Inc. (IMNM)vs › | $1.85B | 15.08 | 9.38 | 7.12 | 8.07 |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.84B | 21.18 | 6.27 | 4.65 | 4.09 |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 1.23 | 1.57 | 2.04 | 2.44 |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.83B | 4.42 | 3.26 | 3.65 | 4.39 |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.92B | 3.84 | 3.30 | 3.38 | 3.69 |
Current Ratio
37.28
Quick Ratio
37.28
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 37.28 |
| 2026-03-31 | 24.75 |
| 2025-12-31 | 19.66 |
| 2025-09-30 | 21.93 |
| 2025-06-30 | 22.42 |
| 2025-03-31 | 15.38 |
| 2024-12-31 | 10.41 |
| 2024-09-30 | 7.38 |
| 2024-06-30 | 10.68 |
| 2024-03-31 | 14.55 |
| 2023-12-31 | 15.03 |
| 2023-09-30 | 18.16 |
| 2023-06-30 | 21.06 |
| 2023-03-31 | 8.65 |
| 2022-12-31 | 9.15 |
| 2022-09-30 | 8.70 |
| 2022-06-30 | 5.18 |
| 2022-03-31 | 2.32 |
| 2021-12-31 | 2.98 |
| 2021-09-30 | 3.10 |
| 2021-06-30 | 4.09 |
| 2021-03-31 | 7.90 |
| 2020-12-31 | 8.33 |
| 2020-09-30 | 9.05 |
| 2020-06-30 | 6.85 |
| 2020-03-31 | 7.47 |
| 2019-12-31 | 11.45 |
| 2019-09-30 | 13.03 |
| 2019-06-30 | 10.50 |
| 2019-03-31 | 4.03 |
| 2018-12-31 | 7.02 |
| 2018-09-30 | 7.90 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 3.11 |
